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Abstract
Background: High school based chlamydia screening has been shown to increase uptake and detect hidden
infections among sexually active adolescents. Our study aimed to: i) examine the proportions of 15–20 year-olds
tested in a high school based screening and previously in clinical practice, ii) determine chlamydia prevalence
according to testing pattern, and iii) examine factors associated with testing in the two settings.
Methods: A population based cross-sectional study was conducted in 5 high schools in Norway in 2009, using
web-questionnaires and Chlamydia trachomatis PCR in first-void urine (800 girls/818 boys, mean age 17.2 years).
Only sexually active participants at risk for chlamydia infections were included in the analyses. Crude and
multivariable logistic regression models were applied with ‘clinic based testing’ and ‘school based screening’
as outcome variables.
Results: 56% of girls and 21% of boys reported previous clinic based testing. In the school based screening, 93%
were tested with no gender difference. 42% of girls and 74% of boys were tested for the first time at school
(‘school-only test’). Both girls with clinic based testing and girls with school-only test had high chlamydia
prevalence (7.3% vs 7.2%). Boys with clinic based testing had twice the prevalence of those with school-only test
(6.2% vs 3.0%, p = 0.01). Half of infections were detected in participants with school-only test. One-fifth were repeat
infections. In multivariable analysis of girls and boys combined, female gender, older age, early sexual debut, no
condom use at first and last intercourse, steady relationship, and higher number of lifetime partners increased the
odds of clinic based testing. The odds of school based screening increased with male gender, academic affiliation,
later sexual debut, condom use at first intercourse, and current urogenital symptoms in multivariable analysis.
Conclusions: More than half the girls had been tested prior to the school based screening and had high
prevalence independent of previous clinic based testing. School screening was mostly associated with factors
unknown to increase chlamydia infection risk, while clinic based testing was associated with traditional risk factors.
The unusually high and equal participation between genders and the detection of a large chlamydia reservoir
confirms the value of school based screening suggesting this approach to be further explored in Norway.
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Background
Adolescents have a disproportionate burden of genital
Chlamydia trachomatis infections, but may not feel at
risk since most infections are asymptomatic and testing
rates remain low [1-3]. Repeat chlamydia infections are
common in adolescents [4]. According to Norwegian
surveillance data, the female to male chlamydia test ratio
has been more than 4 to 1 in age group 15–19 years
with average positivity rates of 15% in girls and 18% in
boys, respectively [2]. Accurate annual testing rates and
rates of repeat testing in the Norwegian adolescent
population cannot be estimated due to lack of unique
personal identifiers. The major predominance of females
is in line with chlamydia screening programmes in other
high-income countries and may reflect gender differ-
ences in health seeking behaviour [5,6].
Norwegian health authorities recommend chlamydia
testing in the presence of clinical symptoms, or if partner
is infected, or in persons younger than 25 years if change
in sexual partner [7]. Testing and treatment in these
groups are free of charge. Test of cure is recommended
5–6 weeks after treatment. The majority of chlamydia
testing among adolescents is done in general practice and
in public youth clinics which are tailored to the needs of
adolescents and are present in most municipalities. Youth
clinics offer contraceptive counselling without parental
consent and all services are free. Most high schools have a
school nurse available part time providing general health
services that only include limited chlamydia testing. Sexu-
ally transmitted infection (STI) clinics are available only in
a few large towns.
Expansion of chlamydia testing from clinical practices
to school based settings has been shown to increase up-
take among adolescents, particularly in boys [8-12]. A
number of extensive chlamydia screening programmes
have been implemented in high schools in the US [9-11],
but less so in Europe [8,13]. In 2009, we conducted a
cross-sectional study on early sexual behaviour and chla-
mydia infection among high school students in Norway.
Among the sexually active, chlamydia prevalence was
7.3% (95% confidence interval, CI, 5.3–9.7%) in girls and
3.9% (2.3–6.0) in boys with infections starting to be ac-
quired soon after sexual initiation [14]. This study pro-
vided an opportunity to examine factors associated with
chlamydia testing in a school based screening and previ-
ously in clinical practice, and to estimate the chlamydia
reservoir in adolescents not seeking testing on their
own. As school based chlamydia screening is not current
policy in Norway, we assumed that previous testing had
been done in clinical practice, ie ‘clinic based testing’.
The objectives of this paper were to; i) examine the
proportion of adolescents aged 15–20 years in Norway
tested in a high school based screening and previously
in clinical practice, ii) determine chlamydia prevalence
according to testing pattern, and iii) examine demographic
and sexual behavioural characteristics associated with
school based screening and previous clinic based testing.
Methods
A detailed description of the study has been reported
elsewhere [14]. In brief, a population based cross-
sectional study was conducted in 5 public high schools
in Finnmark county in Northern Norway in 2009 using a
web-questionnaire and first-void urine (FVU) samples.
All data were collected by the same experienced female
doctor and nurse who consecutively visited a total of
123 classes using an identical approach. Written infor-
mation about chlamydia infection, questionnaire items,
and sampling procedures were handed out in class two
weeks prior to data collection. Confidentiality regarding
questionnaire data and chlamydia test results was as-
sured both in the written information and later by oral
repetition in each class. On the day of data collection, a
web-questionnaire was emailed class-wise to each stu-
dent including questions on demography, substance use,
sexual behaviour, contraceptive use, current urogenital
symptoms, and prior chlamydia testing and treatment.
The teacher and study staff were present in class while
participants filled in the questionnaire on their laptops.
Directly thereafter, participants went on to the school
toilets where they provided about 12 ml FVU samples
under supervision of the study nurse. Samples were
immediately refrigerated and delivered to the labora-
tory on the following day for C. trachomatis PCR
testing (ProCt real-time PCR, ProCelo as, Tromsø,
Norway). Test result notification time was 1–2 days.
Participants testing positive were called on their cell
phone by the nurse and given an appointment at the
local youth clinic. Infections were treated with a sin-
gle dose of 1 gram azithromycin orally.
Overall participation rate was 85% (1,618 of 1,908)
(Figure 1). If only assessing students present at school,
2% (46 of 1,664) refused participation. 442 participants
responding ‘no’ to: ‘Have you ever had sexual inter-
course?’ were considered not to be at risk for chlamydia
infection and were excluded from the analyses. All 442
had negative test results. 1,112 participants reporting
sexual intercourse experience were considered to be at
risk and were included. Mean age was 17.2 years (stand-
ard deviation, SD 1.0, median age 17.0 years).
The variable ‘high school study affiliation’ was defined
as; 1) ‘academic’, including students in the general aca-
demic studies programme, and 2) ‘vocational’, including
vocational school students. In Norway, academic and
vocational classes frequently share facilities throughout
high school.
Previous clinic based testing was assessed by; ‘Have you
previously been tested for genital chlamydia infection?’
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with response options: ‘Yes, once’, ‘Yes, twice’, ‘Yes, 3
times’, ‘Yes ≥ 4 times’, or ‘No’. Due to small groups, the
variable ‘clinic based testing’ was dichotomised as yes/no.
‘School based screening’ included all participants that
were screened in the high school study independent of
clinic based testing. The subgroup ‘school-only test’ in-
cluded participants with no previous clinic based testing
that provided a urine sample in the school based
screening.
Statistical analysis
Descriptive characteristics were reported with means
(SD) for continuous variables and with numbers (%) for
categorical variables. The 95% CI for proportions were
calculated using the exact binominal method. Crude and
multivariable logistic regression models were applied
with two dependent variables: 1) ‘clinic based testing’;
yes/no, and 2) ‘school based screening’; yes/no. All ana-
lyses were performed separately for girls and boys and in
both genders combined. Variables with p value < 0.25 in
crude analysis were included in the multivariable models
which were fitted using stepwise elimination. Age and
gender (if applicable) were included regardless of signifi-
cance. Collinearity was not a problem with variance
inflation factor (VIF) < 2.5 for all variables. Gender
interaction was assessed by including cross-product
terms between each independent variable and gender.
Statistically significant interaction terms were included in
the final multivariable model. Model fit was assessed using
Hosmer and Lemeshow goodness-of-fit test with 5 of 6
p values > 0.25. All statistical tests were two-sided using
a 5% significance level and were performed in SPSS 19.0
(IBM Corp., New York, US).
Ethics
Written informed parental consent was obtained for par-
ticipants < 16 years. Participants ≥ 16 years gave their in-
formed consent by filling in the web-based questionnaire.
The study was approved by the Regional Committees for
Medical and Health Research Ethics North Norway.
Results
Clinic based chlamydia testing was reported by 56% of
girls and 21% of boys (Table 1) with more girls than boys
reporting multiple tests (61% vs 34%, p < 0.001). In the
high school based screening, 93% of sexually active par-
ticipants, 564 of 607 girls and 470 of 505 boys, were
tested with no gender difference (Additional file 1). 42%
of girls and 74% of boys were tested for the first time in
the school based screening, i.e. school-only test.
Chlamydia prevalence
Among participants with previous clinic based testing,
chlamydia prevalence was 7.3% (95% CI 4.7–10.8) in
girls and 6.2% (2.3–13.0) in boys. Among participants
with school-only test, prevalence was 7.2% (4.3–11.1) in
girls, and 3.0% (1.5–5.3) in boys. 50% (n = 29) of the
chlamydia infected participants reported clinic based
testing and 21% (n = 12) reported previous treatment.
Among 41 girls with a positive chlamydia test result in
the school based screening, 23 reported clinic based test-
ing (Table 1). Among 17 boys screening positive at
school, 6 reported previous clinic based testing.
Clinic based testing
In gender-stratified crude analysis, the following vari-
ables increased the odds of clinic based testing in both
Figure 1 Study population.
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Table 1 Sosiodemographic and sexual behaviour characteristics - prevalence and crude odds ratios for clinic
based testing
Girls Boys All participants
Clinic based testing Clinic based testing Interaction
Characteristic N n (%) OR 95% CI p1 N n (%) OR 95% CI p1 p1 p2
Total 607 338 (55.7) NA 505 106 (21.0) NA
Age
15-16 179 81 (45.3) 1.00 < 0.001 149 19 (12.8) 1.00 0.001 < 0.001 0.80
17 193 105 (54.4) 1.44 0.96–2.17 196 40 (20.4) 1.75 0.97–3.18
18 177 104 (58.8) 1.72 1.13–2.62 114 28 (24.6) 2.23 1.17–4.24 ,
19-20 58 48 (82.8) 5.81 2.77–12.20 46 19 (41.3) 4.81 2.25–10.29
Family and culture
Ethnicity ,
Norwegian 433 232 (53.6) 1.00 0.049 353 56 (15.9) 1.00 < 0.001 0.001 0.022
Sami/Sami-Norwegian 131 85 (64.9) 1.60 1.07–2.40 115 37 (32.2) 2.52 1.55–4.08
Other 43 21 (48.8) 0.83 0.44–1.55 36 13 (36.1) 3.00 1.43–6.27
Residence in school year
At home 380 196 (51.6) 1.00 0.007 314 55 (17.5) 1.00 0.015 0.001 0.78
Other3 226 142 (62.8) 1.59 1.13–2.22 191 51 (26.7) 1.72 1.11–2.65
Mothers education
≤ High school/don’t know 338 184 (54.4) 1.00 0.46 334 62 (18.6) 1.00 0.074 0.005 0.32
≥ College 268 154 (57.5) 1.13 0.82–1.56 169 43 (25.4) 1.50 0.96–2.33
High school
Study affiliation
Academic 323 189 (52.1) 1.00 0.029 181 45 (24.9) 1.00 0.11 0.040 0.010
Vocational 244 149 (61.1) 1.44 1.04–2.01 324 61 (18.8) 0.70 0.45–1.09
Alcohol/drug use
Low 144 57 (40.4) 1.00 < 0.001 140 21 (15.3) 1.00 0.003 < 0.001 0.49
Medium 343 193 (56.3) 1.90 1.27–2.82 212 40 (18.9) 1.29 0.72–2.29
High 118 86 (72.9) 3.96 2.34–6.71 144 45 (31.3) 2.51 1.40–4.50
Sexual behaviour
Age at first intercourse
≥ 15 years 352 167 (47.4) 1.00 < 0.001 311 40 (12.9) 1.00 < 0.001 < 0.001 0.15
≤ 14 years 252 171 (67.9) 2.34 1.67–3.28 172 59 (34.3) 3.54 2.24–5.59
Years sexually active
≤ 1 year 162 54 (33.3) 1.00 < 0.001 171 13 (7.6) 1.00 < 0.001 < 0.001 0.50
≥ 2 years 442 284 (64.3) 3.60 2.46–5.26 312 86 (27.6) 4.63 2.50–8.58
Condom use first intercourse
Yes 358 198 (55.3) 1.00 0.78 267 40 (15.0) 1.00 0.001 0.15 0.014
No4 248 140 (56.5) 1.05 0.76–1.45 226 61 (27.0) 2.10 1.34–3.28
Currently in relationship
Yes 322 185 (57.5) 1.00 0.35 179 42 (23.5) 1.00 0.31 0.001 0.79
No 285 153 (53.7) 0.86 0.62–1.18 326 64 (19.6) 0.80 0.51–1.24
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girls and boys: older age, Sami/Sami-Norwegian ethnicity,
residence outside the family home, higher levels of alcohol
and drug use, age at first intercourse ≤ 14 years, sexual ac-
tivity ≥ 2 years, ≥ 2 sexual partners past 6 months, higher
number of lifetime sexual partners, age difference with last
partner ≥ 1 year, and no condom use at last intercourse
(Table 1). Girls in vocational classes had higher odds of
clinic based testing than those with academic affiliation.
No condom use at first intercourse increased the odds of
clinic based testing in boys, but not in girls. Clinic based
testing was not associated with school based screening or
with prevalent chlamydia infection.
In multivariable analysis, the following variables in-
creased the odds of clinic based testing in girls and boys
combined: older age, age at first intercourse ≤ 14 years,
no condom use at first intercourse, steady relationship,
and having had higher number of lifetime partners
(Table 2). No condom use at last intercourse increased
the odds in girls only. Significant interaction was present
between gender and ethnicity (p = 0.012) in the multivar-
iable model. Girls had higher odds of clinic based testing
than boys, but the odds ratio varied by ethnic group.
Among boys, clinic based testing varied between the
three ethnic groups with Norwegian boys having the
lowest test activity. In girls, ethnic group was not associ-
ated with clinic based testing. Nagelkerke’s estimate of
explained variance in the multivariable model for all par-
ticipants was 42%.
School based screening
In girls’ crude analysis, academic affiliation, condom
use at first intercourse, and current urogenital symp-
toms increased the odds of school based screening
(Additional file 1), and these variables remained signifi-
cant in the girls’ multivariable model (Table 3). Among
243 girls reporting ≥ 1 symptom, only 10% had a positive
test result. In boys, age at first intercourse ≥ 15 years
and no prior treatment for chlamydia infection in-
creased the odds of school based screening in crude
analysis, while in multivariable analysis low substance
use, age at first intercourse ≥ 15 years, and no con-
dom use at last intercourse increased the odds. As-
sessing girls and boys combined, the following variables
increased the odds of school based screening in multivari-
able analysis: male gender, academic affiliation, age at first
intercourse ≥ 15 years, condom use at first intercourse,
Table 1 Sosiodemographic and sexual behaviour characteristics - prevalence and crude odds ratios for clinic
based testing (Continued)
Sex partners past 6 months
0-1 352 181 (51.4) 1.00 0.010 273 35 (12.8) 1.00 < 0.001 < 0.001 0.013
≥ 2 248 154 (62.1) 1.55 1.11–2.16 194 62 (32.0) 3.19 2.01–5.09
Life time no of sex partners
1-2 206 64 (31.1) 1.00 < 0.001 218 11 (5.0) 1.00 < 0.001 < 0.001 0.17
3-5 191 107 (56.0) 2.83 1.87–4.26 123 31 (25.2) 6.34 3.06–13.16
≥ 6 201 163 (81.1) 9.52 6.01–15.08 119 53 (44.5) 15.11 7.46–30.62
Last sexual partner
Age difference
Same age or younger 144 66 (45.8) 1.00 0.005 413 80 (19.4) 1.00 0.042 < 0.001 0.78
Older (≥ 1 year) 445 264 (59.3) 1.72 1.18–2.52 54 17 (31.5) 1.91 1.03–3.57
Condom use last intercourse
Yes 94 33 (35.1) 1.00 < 0.001 319 76 (23.8) 1.00 0.009 < 0.001 0.36
No5 513 305 (59.5) 2.71 1.71–4.29 168 23 (13.7) 1.97 1.18–3.28
School based testing
Provision of urine sample
Yes 564 313 (55.5) 1.00 0.74 470 97 (20.6) 1.00 0.48 0.49 0.73
No 43 25 (58.1) 1.11 0.59–2.09 35 9 (25.7) 1.33 0.60–2.93
Chlamydia test result
Negative 523 290 (55.4) 1.00 0.94 448 91 (20.3) 1.00 0.14 0.11 0.23
Positive 41 23 (56.1) 1.03 0.54–1.95 17 6 (35.3) 2.14 0.77–5.94
N, total number of participants in each group; n (%), number (proportion) of participants with clinic based testing; OR, odds ratio; CI, confidence interval; NA,
not applicable; 1p-value for equality between categories; 2p-value for interaction between gender and independent variable; 3Living with relatives, in students’
houses or in private accommodation; 4Includes the response: ‘Uncertain if any contraception was used’ (girls n = 3, boys n = 10); 5Includes the response: ‘Uncertain
if any contraception was used’ (girls n = 3, boys n = 8).
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and current urogenital symptoms. Nagelkerke’s estimate
in the multivariable model for all participants was 6.2%
(Table 3).
The 18 girls and 11 boys with chlamydia infection and
school-only test reported less condom use at both first
and last intercourse, and higher number of sexual partners
past 6 months and during lifetime than non-infected par-
ticipants with school-only test (p < 0.05).
Discussion
We found that a large proportion of adolescent girls had
been tested previously. The unusually high and equal
participation between genders in the school based
screening and the finding of a large undetected pool of
chlamydia infections confirms the value of school based
testing. High school based screening and clinic based test-
ing were associated with completely different independent
Table 2 Odds ratios for clinic based testing in multivariable logistic regression models
Girls Boys All participants1
Characteristic OR 95% CI p2 OR 95% CI p2 OR 95% CI p2
Gender: girls vs boys3
Norwegian NA NA 7.96 5.26–12.04 < 0.001
Sami/Sami-Norwegian NA NA 3.62 1.92–6.82 < 0.001
Other NA NA 1.89 0.66–5.45 0.24
Age
OR per year 1.47 1.20–1.81 < 0.001 1.73 1.28–2.32 < 0.001 1.54 1.30–1.83 < 0.001
Family and culture
Ethnicity girls4
Norwegian ns NA 1.00 0.37
Sami/Sami-Norwegian ns NA 1.30 0.82–2.08
Other ns NA 0.78 0.38–1.60
Ethnicity boys5
Norwegian NA 1.00 < 0.001 1.00 < 0.001
Sami/Sami-Norwegian NA 2.83 1.56–5.13 2.86 1.59–5.14
Other NA 3.53 1.44–8.64 3.28 1.37–7.84
Sexual behaviour
Age at first intercourse
≥15 years 1.00 0.006 1.00 0.003 1.00 < 0.001
≤14 years 1.78 1.18–2.67 2.56 1.39–4.71 2.02 1.43–2.85
Condom use first intercourse
Yes ns ns 1.00 0.013
No6 ns ns 1.48 1.09–2.01
Currently in a relationship
Yes ns ns 1.00 0.009
No ns ns 0.66 0.49–0.90
Lifetime no of sex partners
1-2 1.00 < 0.001 1.00 < 0.001 1.00 < 0.001
3-5 2.42 1.59–3.71 4.22 1.95–9.12 3.07 2.11–4.46
≥6 6.31 3.85–10.34 8.57 3.91–18.79 7.63 5.03–11.55
Condom use last intercourse
Yes 1.00 0.011 ns ns
No7 1.93 1.16–3.20 ns ns
The significant variables from stepwise selection, age and gender (if applicable) were included in the models.
OR, odds ratio; CI, confidence interval; NA, not applicable; ns, non-significant; 1Interaction term between gender and ethnicity included in the model (p 0.012);
2p-value for equality between categories; 3Reference group: boys; 4Odds ratios in girls; 5Odds ratios in boys; 6Includes the response: ‘Uncertain if any
contraception was used’ (girls n = 3, boys n = 10); 7Includes the response: ‘Uncertain if any contraception was used’ (girls n = 3, boys n = 8).
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variables. To have been tested previously was mainly asso-
ciated with traditional risk factors suggesting that these
adolescents were aware of the behavioural determi-
nants of chlamydia infection and thus were motivated
by their own perceived risk. In contrast, school based
screening mostly was associated with factors unknown to
increase risk, strongly indicating the presence of other in-
centives. To our knowledge, this is the first study to com-
pare clinic based testing to school based screening in a
general adolescent population.
The high proportion of girls with clinic based testing is
in agreement with Norwegian surveillance data and other
European studies with young females accessing clinical
test sites much more frequently than same-aged males
[2,15,16]. The lower sexual activity among Norwegian
boys 15–20 years and young males’ reluctance to access
health care services may contribute to less testing [14,17].
The high participation rate in the school based screening
may be explained by the following factors: thorough plan-
ning, the relevant topics, the universal offer to all students
irrespective of sexual history, the ‘in-class’ recruitment
and sampling procedures, the efficient logistics with rapid
notification of positive test results, and this being the first
chlamydia high school based screening in Northern
Norway [18]. It is likely that invitation to participate in re-
search increased uptake. In Norway, repeat school based
studies on adolescent health and lifestyle including bio-
logical samples, have shown sustained response rates
above 85% [19,20] thus suggesting a potential for sustain-
ability of repeat school based chlamydia screening. We
Table 3 Odds ratios for school based screening in multivariable logistic regression models including the significant
variables from stepwise selection
Girls Boys All participants
Characteristic OR 95% CI p1 OR 95% CI p1 OR 95% CI p1
Gender
Girls2 NA NA 0.57 0.34–0.97 0.040
Age
OR per year 0.91 0.65–1.27 0.58 0.82 0.52–1.28 0.39 0.86 0.67–1.11 0.24
High school
Study affiliation
Academic 1.00 0.001 ns 1.00 0.013
Vocational 0.33 0.17–0.65 ns 0.51 0.30–0.87
Alcohol/drug use
Low ns 1.00 0.039 ns
Medium ns 0.75 0.22 to 2.58 ns
High ns 0.26 0.08 to 0.91 ns
Sexual behaviour
Age first intercourse
≥15 years ns 1.00 0.001 1.00 0.029
≤14 years ns 0.23 0.10–0.57 0.58 0.35–0.95
Condom use first intercourse
Yes 1.00 0.010 ns 1.00 0.026
No3 0.42 0.21–0.82 ns 0.57 0.35–0.94
Condom use last intercourse
Yes ns 1.00 0.003 ns
No4 ns 3.86 1.59–9.41 ns
Chlamydia infection
Urogenital symptoms5
No 1.00 <0.001 ns 1.00 0.001
Yes 4.26 1.89–9.63 ns 3.23 1.57–6.65
Age and gender (if applicable) included in the model.
OR, odds ratio; CI, confidence interval; NA, not applicable; ns non-significant, 1p-value for equality between categories; 2Reference group: boys; 3Includes the
response: ‘Uncertain if any contraception was used’ (girls n = 3, boys n = 10); 4Includes the response: ‘Uncertain if any contraception was used’ (girls n = 3,
boys n = 8); 5In girls: dysuri, vaginal discharge, intermenstrual and/or postcoital bleeding. In boys: dysuri and/or urethral discharge.
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observed a curious and welcoming attitude among both
students and staff. Male participants frequently com-
mented on the simplicity of urinating in a cup and the
convenience of a class-wise approach with everyone
getting tested. Adolescent males are more likely to
accept STI testing if the testing procedures are con-
venient [17,21,22] and if they feel that confidentiality
is maintained [23]. Individual provider characteristics
may also impact on their decision [24,25]. The boys’
high acceptance for school based screening challenges
the notion of adolescent males as a hard-to-reach
group as the selection bias normally created by low
participation among boys was not observed.
Chlamydia prevalence
High chlamydia prevalence was detected in girls irre-
spective of earlier test behaviour. Girls with clinic based
testing had higher levels and longer duration of risk be-
haviours than those with school-only test. The equal
infection levels may indicate effect of adherence to rec-
ommendations on testing and treatment in the first
group and less adherence in the school-only test group
among those with high risk behaviours. Boys with clinic
based testing had approximately the same prevalence as
girls. Boys with school-only test having half the preva-
lence of girls is consistent with less sexual activity in
boys this age and thus reduced infection risk [14]. For
girls and boys combined, half of chlamydia cases were
detected in the school-only test group. Correspondingly
these infected subjects had higher levels of risk behav-
iours than participants with school-only test and a nega-
tive chlamydia test result. We may have underestimated
prevalence in girls as C. trachomatis was detected in
FVU samples that are less sensitive than self-collected
vaginal swabs.
Factors associated with testing
Clinic based testing behaviour differing between ethnic
groups among boys may indicate that boys’ testing pat-
terns at this age is more influenced by same-ethnicity
peers and less by national recommendations. In contrast,
girls’ test activity was not associated with ethnicity. Early
first intercourse doubled the odds of clinic based testing
and was positively correlated with number of sexually
active years suggesting that it may reflect a longer sexually
active period with more testing opportunities. In contrast,
participants who just recently started their sexual career
only had limited time to seek chlamydia testing. No con-
dom use at first and last intercourse increasing the odds
of clinic based testing suggests testing for safety reasons.
While condom use at any occasion is a dyadic behaviour
and negotiable between partners, chlamydia testing can
freely be carried out by the individual. Higher lifetime
number of sexual partners being associated with increased
clinic based testing is in agreement with a study on uptake
in the English National Chlamydia Screening Programme
where persons being tested in the programme reported
significantly higher numbers of partners than a random
sample of the general population [26].
In the multivariable model using school based screen-
ing as independent outcome, current urogenital symp-
toms in girls and in both genders combined were the only
significant traditional risk factor. However, symptoms had
low positive predictive value to detect chlamydia infection
which is consistent with other studies [1]. School screen-
ing reached a large proportion of adolescents at no or low
risk of chlamydia infections. Among these, participants
not previously tested in clinical practice may have bene-
fited from learning the test procedure.
One-fifth of all infections were detected in participants
with previous chlamydia treatment and were thus repeat
infections undetected in clinical practice. This may indi-
cate a weakness in the Norwegian testing algorithm. Our
data did not allow any conclusions about the duration of
an infection, or if it was transmitted by the same partner,
by new sexual contacts, or was due to treatment failure
or non-compliance. In addition, we had no information
on time since clinic based testing. Prevalent chlamydia
infection not being associated with clinic based testing
indicates that adolescents do underestimate their own
infection risk as also observed in other studies [27]. Al-
though chlamydia testing in youth clinics is easily avail-
able and free of charge irrespective of the patient
meeting the national test criteria or not, our study shows
that a significant proportion of adolescents at risk had
not been tested before the study suggesting the presence
of other barriers to testing.
The strengths of this study include the representative-
ness achieved by high participation, the use of computer-
based questionnaires to limit social desirability bias, and
the use of high quality biological samples [28].
Limitations
The study is limited by cross-sectional design that pre-
cludes establishing causality and by self-reported data on
sexual behavioural and previous chlamydia treatment.
The presence of some social desirability bias is likely due
to the sensitive topics. Using laboratory data to assess
the outcome variable ‘clinic based testing’ instead of a
questionnaire would have improved validity. However,
longer recall periods have been found accurate for
assessing low-frequency events such as a previous chla-
mydia test [29]. In this paper, we assumed specific sexual
behaviours, i.e. number of sexual partners past 6 months
and circumstances related to last sexual intercourse,
reported before the school screening to be representative
for sexual behaviours before clinic based testing. Our
assumption is based on the finding that single-events
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like the most recent intercourse is valid representa-
tion of sexual behaviour over longer periods of time
[30]. Previous STI test results could have influenced
later sexual behaviour in the direction of less or increased
risk causing a slight attenuation in the observed odds ratio
estimates.
Conclusions
More than half the girls had been tested prior to the
school based screening and had high prevalence inde-
pendent of clinic based testing. While clinic based testing
was associated with traditional chlamydia risk factors,
school based screening was mostly associated with factors
unknown to increase infection risk. The high and equal
participation between genders and the detection of a large
chlamydia reservoir that included both first-time and
repeat infections confirms the value of school based
screening and suggests this approach to be further ex-
plored in Norway.
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